Outlook Therapeutics, Inc. SEC filings OTLK
Outlook Therapeutics, Inc. has 833 filings in SEC EDGAR's recent list, going back to Aug 10, 2015. Its latest annual report, Form ARS, was filed on Jan 26, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 18, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (listing notice). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Jan 26, 2026 | Sep 30, 2025 |
| 10-K | Annual report | Dec 19, 2025 | Sep 30, 2025 |
| ARS | Annual report to shareholders | Feb 10, 2025 | Sep 30, 2024 |
| 10-K/A | Amended annual report | Jan 23, 2025 | Sep 30, 2024 |
| 10-K | Annual report | Dec 27, 2024 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Feb 8, 2024 | Sep 30, 2023 |
| 10-K/A | Amended annual report | Jan 24, 2024 | Sep 30, 2023 |
| 10-K | Annual report | Dec 22, 2023 | Sep 30, 2023 |
| ARS | Annual report to shareholders | Feb 15, 2023 | Sep 30, 2022 |
| 10-K/A | Amended annual report | Jan 24, 2023 | Sep 30, 2022 |
| 10-K | Annual report | Dec 29, 2022 | Sep 30, 2022 |
| 10-K | Annual report | Dec 23, 2021 | Sep 30, 2021 |
| 10-K/A | Amended annual report | Jan 28, 2021 | Sep 30, 2020 |
| 10-K | Annual report | Dec 23, 2020 | Sep 30, 2020 |
| 10-K | Annual report | Dec 19, 2019 | Sep 30, 2019 |
| 10-K | Annual report | Dec 18, 2018 | Sep 30, 2018 |
| 10-K/A | Amended annual report | Jan 29, 2018 | Sep 30, 2017 |
| 10-K | Annual report | Dec 29, 2017 | Sep 30, 2017 |
| 10-K/A | Amended annual report | Jan 27, 2017 | Sep 30, 2016 |
| 10-K | Annual report | Dec 29, 2016 | Sep 30, 2016 |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- OTLK (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Iselin, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1649989
- Former names
- Oncobiologics, Inc. (until Nov 13, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.